SOURCE: Polaris Venture Partners

Polaris Venture Partners

January 07, 2011 13:00 ET

Polaris Venture Partners and Matt Meeker Meet-Up at Dogpatch Labs NYC Co-Founder Named Dogpatch Labs NYC Entrepreneur in Residence

BOSTON, MA--(Marketwire - January 7, 2011) - Polaris Venture Partners today announced that Matt Meeker (@mmeeker), co-founder of, is its newest entrepreneur in residence (EIR) in the New York City Dogpatch Labs. As EIR, Matt will work with early stage entrepreneurs and founders as they conceive of and launch startups and build upon the synergies between the three Dogpatch locations and the alumni network. Dogpatch Labs has now hosted more than 200 entrepreneurs across its NYC, Cambridge, Mass. and San Francisco locations, offering space, connectivity and "open-sourced" collaboration through industry events and open houses that encourage a constant atmosphere of breakthrough innovation.

"Matt has been in the entrepreneur's seat and his success makes him an ideal standard-bearer for our NYC Dogpatch Labs," said Peter Flint (@pflint), General Partner of Polaris Venture Partners. "We have established a strong presence in the greater New York City ecosystem and we're continuing to support this continued growth. Matt is part of that strategy, and we're pleased to have someone of his caliber on board."

"I'm excited to work closely with a new generation of business leaders at Dogpatch Labs," said Matt Meeker. "My own experience confirms how important it is to nurture innovation and expose it to as much like-minded entrepreneurial spirit as possible. It's an unmistakable thrill to build something, and now I get to experience that many times over alongside the best emerging talent in the New York ecosystem."

Dogpatch Labs New York, founded in 2009, is located at 36 East 12th Street in New York City.

About Polaris Venture Partners
Polaris Venture Partners is a partnership of experienced investors, operating executives and entrepreneurs. The firm's mission is to identify, invest in and partner with seed, early stage, and middle-market businesses with exceptional promise and help them grow into market-leading companies. Polaris invests in businesses across a number of markets including technology, digital media, consumer, enertech and life sciences. Polaris-backed successes in life sciences include: Adimab, Adnexus (sold to BMS), Advanced Inhalation Research (sold to Alkermes), Alimera (ALIM), Alnylam Pharmaceuticals (ALNY), Asthmatx (sold to Boston Scientific) Glycofi (sold to Merck), Momenta Pharmaceuticals (MNTA) and Ironwood (IRWD). Polaris-backed successes in technology and consumer include: Akamai Technologies (AKAM), Allaire,, Athlete's Performance, Automattic (WordPress), e-Rewards, LogMeIn (LOGM), LegalZoom, LivingProof, MarkMonitor, Powersoft, Solidworks, TechTarget (TTGT) and Quantcast. For more on the firm, its mission and its portfolio companies:

Contact Information

  • Media Contact
    Scott Bauman
    Greenough Communications
    Email Contact